Scott Evans, PhD, MS

Dr. Scott Evans is a Professor and Founding Chair of the Department of Biostatistics and Bioinformatics and the Director of the Biostatistics Center at Milken Institute School of Public Health of the George Washington University. He is the: Director of the Statistical and Data Management Center for the Antibacterial Resistance Leadership Group (ARLG) funded by NIAID/NIH; the PI of the Coordinating Center for the Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium funded by the NCI/NIH, and the co-PI of the Data Coordinating Center of the Clamp OR Delay among neonates with Congenital Heart Disease (CORD-CHD) clinical trial funded by the NHLBI/NIH. He served as: the Guest Editor of a mini-Series on DSMBs for the NEJM Evidence; a member of an FDA Advisory Committee; and the past-President of the Society for Clinical Trials (SCT). He is a recipient of the Mosteller Statistician Award, the Zackin Distinguished Collaborative Statistician Award, the Founders Award from the American Statistical Association (ASA), an elected member of the International Statistical Institute (ISI), and is a Fellow of the ASA, SCT, and the Infectious Disease Society of America (IDSA).
Financial relationships
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Taylor & FrancisTopic:Book RoyaltiesDate added:10/20/2025Date updated:10/29/2025Relationship end date:10/20/2025
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:Eli LillyTopic:ConsultingDate added:10/20/2025Date updated:10/29/2025Relationship end date:10/20/2025
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:GenFitTopic:ConsultingDate added:10/20/2025Date updated:10/29/2025Relationship end date:10/20/2025
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:Boston PharmaTopic:ConsultingDate added:10/20/2025Date updated:10/29/2025Relationship end date:10/20/2025
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:IDDITopic:ConsultantDate added:10/20/2025Date updated:10/29/2025Relationship end date:10/01/2025
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:RocheTopic:DSMBDate added:10/20/2025Date updated:10/29/2025Relationship end date:10/20/2025
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:PfizerTopic:DSMBDate added:10/20/2025Date updated:10/29/2025Relationship end date:10/20/2025
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:TakedaTopic:DSMBDate added:10/20/2025Date updated:10/29/2025Relationship end date:10/20/2025
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:AkouosTopic:DSMBDate added:10/20/2025Date updated:10/29/2025Relationship end date:10/20/2025
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:ApellisTopic:DSMBDate added:10/20/2025Date updated:10/29/2025Relationship end date:10/20/2025

Facebook
X
LinkedIn
Forward